MYC and glioblastoma: PKM2, but not PKM1, is selectively expressed in proliferating or tumor cells [54,55], and can disassociate HDAC3 from the MYC promoter to promote GBM tumorigenesis through directly binding and phosphorylating histone H3 [56].